SENSOME
13.1.2020 08:02:12 CET | Business Wire | Press release
Sensome, the company pioneering the connected medical device revolution with the world’s smallest biological tissue sensor, announced today the successful completion of a 9 million dollar financing round from its historical investors (Kurma Partners, Idinvest Partners, BNP Paribas Développement, Paris-Saclay Seed Fund) joined by Asahi Intecc Co., Ltd. from Japan, a world leader in guidewire technology. The funds raised will serve to test the clinical performance of Sensome’s first product Clotild® , a proprietary connected guidewire, and get it ready for market. Sensome and Asahi also agreed to a two-year development plan to design a new connected guidewire for the treatment of ischemic stroke, combining Sensome’s proprietary micro-sensor and Asahi’s CHIKAI guidewire.
Acute ischemic stroke, the leading cause of long-term disability, can now be treated by removing the clot blocking the brain blood vessel using mechanical thrombectomy devices. These devices are guided from the groin over a wire. Sensome transforms these guidewires with its tissue sensor to help physicians remove the clot on the first attempt, which is currently achieved in only one out of three cases and greatly improves patient prognosis.
“The future of interventional therapies depends on accessing the right information at the right time. We have developed the technology to empower medical devices with the required connectivity and data, be it in stroke or other medical fields,” said Franz Bozsak, CEO and co-founder of Sensome, and added, “The partnership with Asahi will demonstrate how Sensome’s sensor technology can be integrated seamlessly into any high-performance medical device.”
“The smart guidewire for stroke aims to gather and utilize significant data regarding clot, contributing to better treatment outcomes in intravascular acute ischemic stroke. An easy-to-use high-performance guidewire with onboard sensor will allow the physician to know more about the clot without significant disruption to the current procedure,” explained Masahiko Miyata, CEO of Asahi Intecc. “The combination of Sensome's sophisticated sensor technology and Asahi's guidewire technology is highly synergetic. Asahi is confident that this collaboration will yield a revolutionary smart guidewire with excellent mechanical performance and unique capability.”
About Sensome www.sensome.com
About ASAHI INTECC CO., LTD. www.asahi-intecc.co.jp
About Kurma Partners www.kurmapartners.com
About BNP Paribas Développement www.bnpparibasdeveloppement.com
About Paris-Saclay Seed Fund www.seedfund.parissaclay.com
About Idinvest Partners www.idinvest.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20200112005017/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Charted Launches ERP-Native E-invoicing Across EMEA1.9.2026 14:30:00 CEST | Press release
Expansion will bring Charted E-invoicing across Europe, supporting accounts payable operations with a fully compliant invoicing process that remains embedded inside their ERP Charted, a leading accounts payable automation software and ERP services provider, today announced the expansion of Charted E-invoicing to support multiple countries spanning Europe, including Germany, France, Norway, Sweden, the Netherlands, Denmark and Finland. Further expansion to Italy, Romania, and Poland, will take place by the end of the quarter. These countries follow the official launch of Charted E-invoicing in Belgium, in May 2026. This expansion is designed to cement Charted support for users across EMEA, ensuring companies based in the region transacting on the PEPPOL network can remain compliant while keeping their accounts payable processes embedded inside their ERP. Charted E-invoicing works as a capability within Charted Invoice AI, to receive electronic invoices directly into the AP inbox, keepin
Riskified Expands its Risk Intelligence Platform with ARIA1.9.2026 14:00:00 CEST | Press release
AI Risk Intelligence Analyst (ARIA) gives fraud teams instant answers from their order data, helping them investigate patterns, drill into trends, and act on insights directly within the Riskified Control Center Riskified (NYSE: RSKD), a global leader in ecommerce fraud detection and risk intelligence, today expanded its risk intelligence platform with ARIA (AI Risk Intelligence Analyst), a conversational AI capability built directly into the Riskified Control Center. Fraud teams today have access to vast amounts of data, but solving urgent business questions often still requires exporting files, building reports, or waiting for additional analysis. ARIA changes that by letting merchants ask questions in natural language and get answers in seconds, complete with charts and tables that support the analysis. With direct access to Riskified metrics and their own business-specific reporting logic, ARIA can investigate and quickly answer a wide range of questions within an existing workflow
Vasion® Unlocks Windows PCs on Snapdragon Adoption with Native, Driverless Printing1.9.2026 14:00:00 CEST | Press release
Eliminating One of the Last Barriers to Enterprise Windows Modernization Vasion is removing a critical barrier to modern Windows device adoption with native, driverless printing for PCs powered by Snapdragon® compute processors. The Vasion Spring 2026 release delivers a seamless, cloud-native print experience, eliminating the need for printer drivers, emulation, or parallel print environments. The collaboration with Qualcomm Technologies combines the PC ecosystem reach of Snapdragon with Vasion's print automation expertise. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260901581087/en/ Vasion fully supports Windows devices powered by Snapdragon with full Internet Printing Protocol (IPP) driverless printing support, enabling IT teams to modernize device fleets without disrupting operations or rearchitecting existing environments. Vasion fully supports Windows devices powered by Snapdragon with full Internet Printing Protocol
Perma-Pipe and Welspun Announce Memorandum of Understanding to Establish Pipe Manufacturing and Coating Facilities in Jordan1.9.2026 14:00:00 CEST | Press release
Strategic Partnership to Establish Integrated Pipe Manufacturing and Coating Capabilities to Support Water, Oil & Gas, and Infrastructure Projects in Jordan and the Levant Region. Perma-Pipe International Holdings, Inc. (Nasdaq: PPIH) (“Perma-Pipe” or the “Company”), a global leader in engineered pipe solutions specialising in anti-corrosion coatings, insulation solutions, containment systems, custom fabrication and leak detection, today announced that it has signed, together with Welspun Corp Limited (“Welspun”), a Memorandum of Understanding (“MOU”) with the developers of Jordan’s National Water Carrier Project and the Government of the Hashemite Kingdom of Jordan to advance the development of pipe manufacturing and advanced coating facilities in Jordan. The parties intend to establish a joint venture to support the development and operation of these facilities. Transaction Description Under the terms of the MOU, Perma-Pipe and Welspun have partnered to establish an integrated pipe m
Compass Pathways to Participate in 2026 Cantor Global Healthcare Conference on September 9, 20261.9.2026 12:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that management will attend the 2026 Cantor Global Healthcare Conference on September 9, 2026 and will participate in a fireside chat at 3:20pm ET and a panel entitled “PSYCH! Accessing The New Wave of Psychedelics” at 4:30pm ET. A live audio webcast of the fireside chat will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways We believe mental health patients deserve the possibility of a better future. Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care. Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resis
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom